AzTrials
AzTrials

Feasibility StudiesTechCareNCT02439619

TechCare: Mobile-AssessmenT and ThErapy for PsyCHosis: An Intervention for Clients Within the EArly InteRvention SErvice

A study testing TechCare in people with Feasibility Studies, run by Lancashire Care NHS Foundation Trust at 1 site in United Kingdom.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the project is to conduct a feasibility study of the mobile phone application "TechCare" for individuals with psychosis in the North West of England. Read more about this study

Who is it for?
Ages 18 to 35 years
Conditions the study is for
Feasibility Studies
What is being tested?
TechCare
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited Kingdom
Study dates
Oct 2014to Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Each client must be accepted into the Psychosis Group of the Lancashire Early Intervention Service.
  • Ages 18 - 35 years
  • Medication stable for previous two months
  • Clients must be currently stable-The Lancashire Early Intervention Team uses a traffic light system to indicate current symptomatology and risks of each client. For this study we will use only clients with a Green Light, signifying that they are currently stable.
  • A score of 3 or more on positive symptoms on the PANSS
  • Minimum score of 1 on the Calgary depression scale.

Who cannot join

  • Drug induced psychosis
  • An acquired brain injury or learning disability
  • Clients who are undergoing assessment, not formally diagnosed and accepted into the service.
  • Lacking capacity for informed consent.
  • Ultra High Risk of Developing Psychosis Group (i.e. Prodromal, not first episode)

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site, 1 recruiting
  • Lancashire Care NHS Foundation Trust

    Preston, Lancashire, PR2 8DW

    Charlotte Bee, PhD, 01772 773498, charlotte.bee@lancashirecare.nhs.uk

    Nadeem Gire, BSc MSc, 07507847569, nadeem.gire@lancashirecare.nhs.uk

    Recruiting

Other trials in United Kingdom

About this study

The aim of the project is to conduct a feasibility study of the mobile phone application "TechCare" for individuals with psychosis in the North West of England.

Read the detailed description

This feasibility study will follow the NIHR guidance on feasibility study design (NIHR, 2014) and will consist of both qualitative and quantitative components. The study will run across three strands as follows 1) Qualitative work \& Systematic review 2) Test run and Intervention refinement 3) Feasibility trial.

Being tested
TechCare

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TechCareOther

    The TechCare software is being developed specifically for use on a touch screen mobile phone. The mobile application will alert participants through notifications and ask a number of questions. Based on participant responses the app will provide a CBT based response to individuals or the service users preferred multimedia such as music, images and videos.

Study groups in NCT02439619
Study groupRoleWhat they receive
Feasibility TrialExperimentalNot described
Receives: Other: TechCare

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility and Acceptability

    We will measure feasibility and acceptability by exploring whether appropriate individuals can be identified and recruited to an open trial of TechCare; whether TechCare is an acceptable intervention for individuals with psychosis and what measures will be important for assessing the impact of TechCare on delusions and low mood in psychosis.

    Measured: 36 months

Secondary outcomes (8)
  1. Psychopathology on The Positive and Negative Syndrome Scale (PANSS)

    The 30- item PANSS, is a clinician administered 30 item semi structured interview which provides balanced representation of positive symptoms and negative symptoms and gauges their relationship to one another and to global/general psychopathology

    Measured: 24 months

  2. Psychopathology on The Psychotic Symptom Rating Scales (PSYRATS)

    The PSYRATS is a semi-structured interview measuring dimensions of delusions and hallucinations.

    Measured: 24 months

  3. Satisfaction with CBT therapy on the CHoice of Outcome In Cbt for psychosEs

    This is an outcome measure which reflects the aims of cognitive behavioural therapy for psychosis and the priorities of service users.

    Measured: 24 months

  4. Mental wellbeing on the Warwick-Edinburgh Mental Well Being Scale (WEMWBS)

    The WEMWBS is a measure of mental wellbeing which focuses entirely on positive aspects of mental health.

    Measured: 24 months

  5. Measure of core beliefs regarding self and others on the Brief Core Schema Scale

    This is a 24 item measure of core beliefs regarding self and others. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.

    Measured: 24 months

  6. Depression on the Calgary depression scale

    The CDS was developed to measure the level of depression in schizophrenia. It is a nine item scale which allows for the quantitative and subjective dimension of depression in schizophrenia.

    Measured: 24 months

  7. Work and social functioning on The Work and Social Adjustment Scale

    This is a five item measure of perceived impairment in five areas: work, home management, social life, private leisure and relationships

    Measured: 24 months

  8. Quality of life on the EuroQoL-5 Dimensions EQ5-D

    the measure is standardised instrument looking at quality of life across five health domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression).

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2015 (estimated)
  2. Study startOct 2014
  3. Primary completionSep 2016 (estimated)
  4. Study completionSep 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02439619
Sponsor's protocol ID
TechCare-LCFT
Acronym
TechCare
Status last verified
May 2015
First submitted
5 May 2015
Last updated
12 May 2015
Results posted
No
Data monitoring committee
Yes

Publications

  • Gire N, Caton N, McKeown M, Mohmed N, Duxbury J, Kelly J, Riley M, J Taylor P, Taylor CDJ, Naeem F, Chaudhry IB, Husain N. 'Care co-ordinator in my pocket': a feasibility study of mobile assessment and therapy for psychosis (TechCare). BMJ Open. 2021 Nov 16;11(11):e046755. doi: 10.1136/bmjopen-2020-046755.

    PubMed 34785541

Questions about this trial

What is this clinical trial studying?

A study testing TechCare in people with Feasibility Studies, run by Lancashire Care NHS Foundation Trust at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 May 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Charlotte Bee, PhD (01772 773498, charlotte.bee@lancashirecare.nhs.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility and Acceptability (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02439619, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in